AzTrials
AzTrials

Tooth SocketNCT05437744

Immediately Placed Implant Sealed With Platelets Rich Fibrin Versus Cyanoacrylate Glue

A study testing Cyanoacrylate glue and Platelet-rich fibrin (PRF) in people with Tooth Socket, run by Hams Hamed Abdelrahman at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The health of peri-implant soft tissues is one of the most important aspects necessary for the long-term survival of dental implants. The importance of the peri-implant mucosal region lies in the need to establish a tight seal that isolates the implant and the bone from the oral environment. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Tooth Socket
What is being tested?
Cyanoacrylate glue and Platelet-rich fibrin (PRF)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteEgypt
Study dates
12 Dec 2021to 1 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Any non-restorable hopeless tooth; a badly decayed tooth that cannot be restored, a Tooth with failed endodontic treatment, and tooth with longitudinal fracture.
  • Post-extraction sockets type 1 with all bony walls intact; Type I extraction sockets according to Elian classification in 2007 have an intact labial plate of the bone and no soft tissue recession. Therefore, it does not require a mucoperiosteal flap elevation, only bone graft particles are packed into the socket after atraumatic extraction and socket debridement, then sealed with barrier membranes or soft tissue graft
  • A good standard of oral hygiene.
  • No signs of active periodontal disease in the selected tooth.

Who cannot join

  • The presence of any systemic disease that could complicate bone or soft tissue healing after immediate implant placement.
  • The presence of Acute periapical infection.
  • The presence of any local factor that may interfere with extraction as tooth ankyloses. (
  • Subjects who had undergone therapeutical radiation. (38)
  • Patients who had been subjected to or who were under bisphosphonate therapy

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Alexandria Faculty of Dentistry

    Alexandria

Other trials in Egypt

About this study

Official title: Assessment of Soft Tissue Healing Over Immediately Placed Implant Sealed With Platelets Rich Fibrin (Prf) Versus Cyanoacrylate Glue (a Randomized Controlled Clinical Trial)

The health of peri-implant soft tissues is one of the most important aspects necessary for the long-term survival of dental implants. The importance of the peri-implant mucosal region lies in the need to establish a tight seal that isolates the implant and the bone from the oral environment. Study objective is to clinically compare the soft tissue healing, height, and thickness over immediate implants placed in type I sockets sealed by PRF to those sealed by a Cyanoacrylate glue.

Read the detailed description

the study will be conducted on 16 extraction sockets in humans. Sockets will be randomly divided into two groups: Group I (test) will comprise 8 sockets sealed by PRF after immediate implant placement. Group II: (test) will comprise 8 sockets sealed by cyanoacrylate glue after immediate implant placement

Conditions
Tooth Socket
Being tested
Cyanoacrylate glue, Platelet-rich fibrin (PRF)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cyanoacrylate glueOther

    8 sockets that will be treated by immediate implant placement and sealed by a Cyanoacrylate glue.

  • Platelet-rich fibrin (PRF)Other

    8 sockets that will be treated by immediate implant placement and sealed by PRF.

Study groups in NCT05437744
Study groupRoleWhat they receive
Study groupExperimentalNot described
Receives: Other: Cyanoacrylate glue
Control groupActive comparatorNot described
Receives: Other: Platelet-rich fibrin (PRF)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in soft tissue healing

    Soft tissue healing will be assessed in both groups in reference to the soft tissue healing index according to Landry index Landry index scores

    Very poor: Tissue color: ≥50% of gingiva red Response to palpation: BleedingGranulation tissue: PresentIncision margin: Not epithelialized, with loss of epithelium beyond incision marginSuppuration: Present

    Poor: Tissue color: ≥50% of gingiva red Response to palpation: BleedingGranulation tissue: PresentIncision margin: Not epithelialized, with connective tissue exposed

    Good: Tissue colour: ≥25% and<50% of gingiva redResponse to palpation: No bleedingGranulation tissue: NoneIncision margin: No connective tissue exposed

    Very good: Tissue colour: <25% of gingiva redResponse to palpation: No bleedingGranulation tissue: NoneIncision margin: No connective tissue exposed

    Excellent: Tissue color: All tissues pinkResponse to palpation: No bleedingGranulation tissue: NoneIncision margin: No connective tissue exposed

    Measured: at 2nd week and 4th week

  2. Change in Mid crestal soft tissue thickness

    Mid crestal soft tissue thickness over the immediate implant will be measured using a periodontal probe passing through soft tissue in the intersection midpoint of both buccolingual and mesiodistal dimensions of the socket till cover screw, after 4 weeks postoperatively

    Measured: at baseline and after 4 weeks

  3. change in Mid-buccal soft tissue height

    Mid-buccal soft tissue height: will be measured from gingival margin to implant platform, at surgery time and 4 weeks postoperatively

    Measured: at baseline and after 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2022
  2. Study start12 Dec 2021
  3. Primary completion1 Aug 2022 (estimated)
  4. Study completion1 Aug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05437744
Sponsor's protocol ID
Cyanoacrylates_2021
Status last verified
Jun 2022
First submitted
27 Jun 2022
Last updated
29 Jun 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Cyanoacrylate glue and Platelet-rich fibrin (PRF) in people with Tooth Socket, run by Hams Hamed Abdelrahman at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in soft tissue healing (time frame: at 2nd week and 4th week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in